Stay updated on Targeting PD-1 Therapy Resistance With Radiation Clinical Trial

Sign up to get notified when there's something new on the Targeting PD-1 Therapy Resistance With Radiation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Targeting PD-1 Therapy Resistance With Radiation Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating an update in the study record related to immunotherapy in combination with radiation therapy as a treatment for head & neck cancer that has worsened or spread to another organ or part of the body.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:00.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments. Additionally, the inclusion criteria now specify that patients must have pathologically confirmed squamous cell carcinoma of the head and neck with evidence of metastatic disease considered incurable by local therapies.
    Difference
    48%
    Check dated 2024-05-22T21:12:04.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:42:57.000Z thumbnail image

Stay in the know with updates to Targeting PD-1 Therapy Resistance With Radiation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Targeting PD-1 Therapy Resistance With Radiation Clinical Trial page.